TC
HALO icon

Titleist Capital’s Halozyme HALO Stock Holding History

Titleist Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$273K Buy
+4,794
New +$245K 0.06% 189
2022
Q3 		– Sell
-4,794
Closed -$211K – 239
2022
Q2 		$211K Buy
+4,794
New +$207K 0.05% 213

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Titleist Capital's HALO Position: Q4 2022 in Review

Titleist Capital opened a new position in Halozyme (HALO) in Q4 2022: 4,794 shares worth $273K. The stake represents 0.06% of the portfolio and ranks #189 among its holdings. This is a return to the name: Titleist Capital previously reported a position in HALO as recently as Q2 2022.

Titleist Capital first reported a position in HALO in Q2 2022 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Titleist Capital held 4,794 shares of Halozyme worth $273K as of Q4 2022.
  • Halozyme was a new Titleist Capital position in Q4 2022.
  • Halozyme made up 0.06% of Titleist Capital's portfolio in Q4 2022, its #189 holding.
  • Titleist Capital first reported a position in Halozyme in Q2 2022 and has held it in 2 quarters since.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.